Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts

被引:17
作者
Burt, E. C. [1 ]
James, L. A. [1 ]
Greaves, M. J. [1 ]
Birch, J. M. [2 ]
Boyle, J. M. [1 ]
Varley, J. M. [1 ]
机构
[1] Paterson Inst Canc Res, CRC Canc Genet Grp, Wilmslow Rd, Manchester M20 48X, Lancs, England
[2] Royal Manchester Childrens Hosp, CRC Paediat & Familial Canc Res Grp, Manchester M27 1HA, Lancs, England
关键词
Li-Fraumeni Syndrome; CGH; LOH; TP53; fibroblasts;
D O I
10.1054/bjoc.2000.1292
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies of Li-Fraumeni syndrome fibroblasts heterozygous for germline TP53 mutations have shown that loss of heterozygosity (LOH) occurs during passaging and is associated with genomic instability, such as chromosomal aberrations and aneuploidy. to investigate the genomic changes associated with LOH in Li-Fraumeni (LF) fibroblasts, we have analysed cell strains at increasing population doublings (PD) using Comparative Genomic Hybridization (CGH). We have looked at three groups of cell strains: LF mutation-carrying strains which showed LOH for TP53, LF mutation-carrying strains which did not show LOH, and strains from normal individuals. Using CGH, we have detected loss of distinct chromosomal regions associated with LOH in 4 out of 5 mutation-carrying strains. In particular we have found loss of chromosomal regions containing genes involved in cell cycle control or senescence, including loss of 9p and 17p in these strains. Other recurrent changes included loss of chromosomes 4q and 6q, regions shown to contain one or more tumour suppressor genes. No genomic alterations were detected at cumulative PD in the normal strains or in the LF mutation-carrying strains which did not show LOH for TP53. We have also analysed the three groups of strains for microsatellite instability and somatic TP53 mutations, and have found genetic alterations in only one strain. (C) 2000 Cancer Research Campaign
引用
收藏
页码:467 / 472
页数:6
相关论文
共 32 条
[1]  
Bentz M, 1998, GENE CHROMOSOME CANC, V21, P172, DOI 10.1002/(SICI)1098-2264(199802)21:2<172::AID-GCC14>3.3.CO
[2]  
2-T
[3]  
Bertram MJ, 1999, MOL CELL BIOL, V19, P1479
[4]  
BIRCH JM, 1994, CANCER RES, V54, P1298
[5]   Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations [J].
Boyle, JM ;
Greaves, MJ ;
Camplejohn, RS ;
Birch, JM ;
Roberts, SA ;
Varley, JM .
BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) :1657-1664
[6]   Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families [J].
Boyle, JM ;
Mitchell, ELD ;
Greaves, MJ ;
Roberts, SA ;
Tricker, K ;
Burt, E ;
Varley, JM ;
Birch, JM ;
Scott, D .
BRITISH JOURNAL OF CANCER, 1998, 77 (12) :2181-2192
[7]  
Bryce SD, 1999, CANCER RES, V59, P2038
[8]   FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS [J].
CAIRNS, P ;
POLASCIK, TJ ;
EBY, Y ;
TOKINO, K ;
CALIFANO, J ;
MERLO, A ;
MAO, L ;
HERATH, J ;
JENKINS, R ;
WESTRA, W ;
RUTTER, JL ;
BUCKLER, A ;
GABRIELSON, E ;
TOCKMAN, M ;
CHO, KR ;
HEDRICK, L ;
BOVA, GS ;
ISAACS, W ;
KOCH, W ;
SCHWAB, D ;
SIDRANSKY, D .
NATURE GENETICS, 1995, 11 (02) :210-212
[9]  
Couch FJ, 1999, CANCER RES, V59, P1408
[10]   A comprehensive genetic map of the human genome based on 5,264 microsatellites [J].
Dib, C ;
Faure, S ;
Fizames, C ;
Samson, D ;
Drouot, N ;
Vignal, A ;
Millasseau, P ;
Marc, S ;
Hazan, J ;
Seboun, E ;
Lathrop, M ;
Gyapay, G ;
Morissette, J ;
Weissenbach, J .
NATURE, 1996, 380 (6570) :152-154